The most recent trading session ended with e.l.f. Beauty (ELF) standing at $77.15, reflecting a -1.36% shift from the previouse trading day's closing. This change lagged the S&P 500's daily gain of 0.1%. Meanwhile, the Dow experienced a drop of 0.21%, and the technology-dominated Nasdaq saw an increase of 0.72%.Prior to today's trading, shares of the cosmetics company had gained 49.91% over the past month. This has outpaced the Consumer Staples sector's loss of 1.24% and the S&P 500's gain of 9.86% in that ...

一个小时60万件国货秒售罄，专门为老年人开了"大字慢速"直播间……昨天晚上，众多平台已经开始抢跑618，并且陆续晒出最新战报，而消费者体验发 现，今年的618更加简单直白，细分赛道服务凸显。 扬子晚报/紫牛新闻记者 徐晓风 | | 618大促满减时间 | | | | | | | --- | --- | --- | --- | --- | --- | --- | | 同期 | 展期二 屋期四 星期一 | 10.29 1 | 星期三 | | 服期五 | 服務方 | | 国用 | 5月5日 5月6日 5月9日 5月10日 | 5月11日 | 5月7日 | 5月8日 | | | | 1动 | 510周年庆(5.6日晚20点-5.12日) | | | | | | | | 玩法:分品类立减10%-15%起 | | | | | | | | 其他:首尾2场(前4小时)前N秒杀价 | | | | | | | 目開 | 5月12日 5月13日 | 5月15日 5月16日 5月17日 5月18日 | 5月14日 | | | | | 「动 | 618 HI W | | | | | | | | (5.13日晚20点-5.16日 618 ...

Company Performance - European Wax Center, Inc. (EWCZ) reported quarterly earnings of $0.22 per share, exceeding the Zacks Consensus Estimate of $0.05 per share, and up from $0.13 per share a year ago, representing an earnings surprise of 340% [1] - The company posted revenues of $51.43 million for the quarter ended March 2025, surpassing the Zacks Consensus Estimate by 4.11%, although this is a slight decrease from year-ago revenues of $51.87 million [2] - Over the last four quarters, the company has consistently surpassed consensus EPS estimates four times and topped consensus revenue estimates two times [2] Stock Outlook - European Wax Center shares have declined approximately 40.6% since the beginning of the year, contrasting with the S&P 500's gain of 0.1% [3] - The company's earnings outlook is favorable, with a current consensus EPS estimate of $0.12 on revenues of $57.77 million for the coming quarter, and $0.31 on revenues of $211.81 million for the current fiscal year [7] - The estimate revisions trend for European Wax Center is currently favorable, resulting in a Zacks Rank 1 (Strong Buy) for the stock, indicating expected outperformance in the near future [6] Industry Context - The Cosmetics industry, to which European Wax Center belongs, is currently ranked in the bottom 24% of over 250 Zacks industries, suggesting potential challenges ahead [8] - The performance of European Wax Center may be influenced by the overall outlook for the industry, as research indicates that the top 50% of Zacks-ranked industries outperform the bottom 50% by more than 2 to 1 [8]

Financial Data and Key Metrics Changes - Revenue for Q1 2025 totaled $2,810,000, representing a 121% increase year over year compared to $1,270,000 in Q1 2024 [4][20] - Gross margins normalized to 42.4%, compared to 37% in Q4 2024 and 43.6% in Q3 2024 [4][21] - EBITDA loss narrowed to negative $540,000 from negative $840,000 in the same period last year [5][22] - Net loss for Q1 2025 was $710,000, down from a net loss of $850,000 in Q1 2024 [22] Business Line Data and Key Metrics Changes - Contract manufacturing revenue increased by 58% year over year, driven by demand from existing customers and new partnerships [4][5] - Consumer branded products revenue surged by 189% year over year, significantly boosted by the addition of Silly George [4] - The entire consumer products portfolio saw strong expansion, with new product launches planned for 2025 [11][12] Market Data and Key Metrics Changes - The company is experiencing increased interest in U.S.-made gels due to potential tariff impacts, which may enhance competitiveness against imported products [17][18] - There is a robust pipeline of new and potential customers for 2025, indicating strong market demand [8][19] Company Strategy and Development Direction - The company aims to expand its product lines, including new offerings for MetaGel and Cancoderm, and is transitioning Silly George into a broader beauty brand [12][13] - Strategic partnerships, such as with Stata, are expected to drive growth, with plans for additional product launches in 2025 and 2026 [14][30] - The company is monitoring tariff situations closely and is prepared to adjust manufacturing strategies if necessary [15][16] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in the product launch with AbbVie, despite delays, and sees it as a substantial opportunity [8][51] - The company does not foresee any weakness in consumer product sales and maintains guidance of $13,000,000 in revenue for 2025 [19][58] - Management is optimistic about achieving cash flow positivity in 2025, supported by ongoing innovation and growth [19][22] Other Important Information - The company has a cash balance of approximately $1,190,000 as of March 31, 2025 [22] - The company is exploring various financing options but prefers to avoid debt until achieving EBITDA positivity [48][64] Q&A Session Summary Question: How much revenue was expected from AbbVie, and does the delay affect guidance? - Management indicated that not much revenue was baked in from AbbVie, so the delay should not impact the projection of $13,000,000 [25] Question: Can you provide details on the product launching with Stata? - The first product is Histosol, a digestive enzyme, with plans for additional digestive enzymes in the future [30] Question: Is there a seasonal decline in Silly George sales? - Management noted a slight decline but emphasized that it was the most profitable quarter despite being smaller than previous quarters [57] Question: Will transitioning manufacturing to Texas impact other business lines? - Management confirmed that there is enough capacity in the new clean room to accommodate potential shifts in manufacturing [35] Question: Will the company survive on current cash reserves until EBITDA positive? - Management believes they can manage with current cash reserves until reaching EBITDA positivity [64]

Financial Data and Key Metrics Changes - Revenue for Q1 2025 was $2,810,000, representing a 121% increase year over year compared to $1,270,000 in Q1 2024 [5][21] - Gross margins normalized to 42.4%, compared to 37% in Q4 2024 and 43.6% in Q3 2024 [5][22] - EBITDA loss narrowed to negative $540,000 from negative $840,000 in the same period last year [6][23] - Net loss for Q1 2025 was $710,000, down from a net loss of $850,000 in Q1 2024 [23] Business Line Data and Key Metrics Changes - Contract manufacturing revenue increased by 58% year over year, driven by demand from existing customers and new partnerships [5] - Consumer branded products revenue surged by 189% year over year, significantly boosted by the addition of Silly George [5] - The company expects continued growth in both contract manufacturing and consumer products, with a robust pipeline for 2025 [8][11] Market Data and Key Metrics Changes - The company is seeing increased interest in U.S.-made gels due to potential tariff impacts, which may enhance competitiveness against imported products [19] - There is a growing market for hydrogel applications, particularly in laser hair removal, with significant interest from major companies [42] Company Strategy and Development Direction - The company plans to expand its product lines, including new offerings for MetaGel and Cancoderm, and is transitioning Silly George into a broader beauty brand [12][13] - The partnership with Stata is progressing well, with plans for additional product launches in 2025 and 2026 [14] - The company is strategically managing cash and R&D to ensure high ROI while pursuing growth opportunities [14] Management's Comments on Operating Environment and Future Outlook - Management remains optimistic about achieving $13,000,000 in revenue and cash flow positivity in 2025 despite external challenges [20] - The company is monitoring tariff situations closely and is prepared to adjust manufacturing strategies if necessary [16][19] - Management expressed confidence in the growth potential of their products and the overall market, despite uncertainties in the broader economic environment [60] Other Important Information - The company has a cash balance of approximately $1,190,000 as of March 31, 2025 [23] - The company has 7,654,537 shares of common stock outstanding as of May 13, 2025 [23] Q&A Session Summary Question: How much revenue was expected from AbbVie, and does the delay affect guidance? - Management indicated that not much revenue was baked in from AbbVie, so the delay should not significantly impact the $13,000,000 projection [25][26] Question: Can you provide details on the product launch with Stata? - The first product is Histosol, a digestive enzyme, with plans for additional digestive enzymes in the future [30] Question: Is there a seasonal improvement expected for Silly George? - Management expects seasonal growth, especially with new product launches planned for Q3 and Q4 [61][62] Question: Will transitioning manufacturing to Texas impact other business lines? - The company has built a new clean room with enough capacity to accommodate potential shifts in manufacturing [35][36] Question: Will the company survive on current cash reserves until EBITDA positive? - Management believes they can manage with current cash reserves until reaching EBITDA positivity [66]

5月12日，2025中国国际美容化妆洗涤用品博览会（第29届CBE中国美容博览会）启幕。产业领军人物、美妆精英及国际嘉宾聚 力出席，共同启动"CBE全球美妆节"及法国主宾国仪式。时代浪潮下的全球美妆产业新机遇、新动能，在上海在CBE激荡涌 动。 第29届CBE中国美容博览会以"全球新品，首发上海"为年度主题，迎来全球40多个国家及地区的3200多家化妆品企业参展，覆 盖24个大品类、119个细分品类。10000多个美妆品牌，80000多个美妆新品爆品、科技成果同台竞技，以"首发上海∙2025CBE全 球美妆节"震撼领衔的150场创新特备活动精彩举办…… 展会第一天，来自海内外化妆品全产业链的品牌企业，全国各省市的线上线下渠道精英，欧美、亚洲的国际买家团，以及国内 外协会商会、权威主流媒体、专家等汇聚在此，展会三天预计吸引超过100个国家及地区的数十万人次的全球化妆品从业者进入 展会现场商贸洽谈、逛展打卡。 转自：潮新闻 依托科技创新与消费转型双重驱动，中国化妆品产业正展现出强劲的产业韧性与创新发展活力。 全球新品首发上海，引领美妆产业新浪潮 作为上海"首发经济"重点展会，第29届CBE中国美容博览会成为海内外 ...

Core Viewpoint - Bragar Eagel & Squire, P.C. is investigating potential claims against The Estee Lauder Companies Inc. regarding alleged breaches of fiduciary duties by its board of directors following a class action complaint filed on December 7, 2023 [1] Group 1: Allegations and Market Impact - The complaint alleges that Estee Lauder misled investors with unrealistic and materially false statements about market demand for its products and inventory levels [2] - These misleading statements concealed the company's market weaknesses until May 3, 2023, when Estee Lauder announced weaker-than-expected sales and profit, leading to a third consecutive cut in its fiscal year outlook [2] - Following this announcement, Estee Lauder's stock price fell from $245.22 per share on May 2, 2023, to $202.70 per share on May 3, 2023, reflecting a significant decline [2]

Company Overview - L'Oréal is the world's leading beauty player with a history of 115 years, focusing on fulfilling global beauty aspirations [2] - The company operates with a broad portfolio of 37 international brands and emphasizes sustainability through its L'Oréal for the Future program [2] Financial Performance - In 2024, L'Oréal generated sales of 43.48 billion euros, showcasing its strong market presence [3] - The company employs over 90,000 individuals and maintains a balanced geographical footprint across various distribution networks, including e-commerce and retail [3] Research and Innovation - L'Oréal has 21 research centers in 13 countries, supported by a dedicated team of over 4,000 scientists and 8,000 digital talents [3] - The company aims to become a Beauty Tech powerhouse, focusing on inventing the future of beauty [3] Shareholder Information - As of April 30, 2025, L'Oréal has a total of 534,315,364 shares, with 533,856,397 real voting rights [1]

市场监管人员对在售化妆品小样进行检查 标识标签不全被立案调查 小样产品和正装产品除规格外应保持一致，产品注册或者备案的相关内容也要一致。六合区市场监管人员发现这些香水小样的包装上贴有简易标签，但标 签内容仅含有成品名称、容量、售价，未标识生产商、注册备案信息、生产日期、有效期、使用方法等内容。 根据《化妆品监督管理条例》有关规定，六合区局执法人员责令经营者立即整改，对其涉嫌经营标识标签不全化妆品的行为立案调查，并向其宣传化妆品 相关法律法规。 化妆品生产许可证不可少 《化妆品标签管理办法》第十七条规定，化妆品净含量不大于15克或者15毫升的小规格包装产品，仅需在销售包装可视面标注产品中文名称、特殊化妆品 注册证书编号、注册人或者备案人的名称、净含量、使用期限等信息，其他应当标注的信息可以标注在随附于产品的说明书中。具有包装盒的小规格包装 产品，还应当同时在直接接触内容物的包装容器上标注产品中文名称和使用期限。 化妆品小样不仅便于携带，而且具有性价比高、试错成本低的优势，近年来颇受消费者欢迎。但您买的小样真的靠谱吗？ 南京市六合区市场监管局执法人员新近在日常检查中发现，某化妆品店多款在售的香水小样标签内容不符合 ...

SEOUL, South Korea, May 9, 2025 /PRNewswire/ -- BRING GREEN, the vegan K-beauty skincare brand from CJ Olive Young, South Korea's largest beauty retailer, is launching its Tea Tree Cica sun care line in the U.S. market via Amazon this May. The new products include the Tea Tree Cica Facial Sun Cushion and Tea Tree Cica Sun Cream, both featuring a lightweight formula tailored for sensitive skin. BRING GREEN’s Tea Tree Cica Sun Duo Facial Sun Cushion and Sun Cream for calm, protected skin. BRING GREEN's s ...